Beta Bionics (BBNX) Other Working Capital Changes (2024 - 2025)

Beta Bionics' (BBNX) quarterly Other Working Capital Changes came in at $526000.0 in Q4 2025, down 55.23% year-on-year from $1.2 million in Q4 2024, and up 3316.47% quarter-over-quarter from $15396.0 in Q3 2025.

Beta Bionics (BBNX) Other Working Capital Changes (2024 - 2025) Analysis & Trends

Beta Bionics has disclosed Other Working Capital Changes across 2 years of filings, most recently posting $526000.0 for Q4 2025.

  • Other Working Capital Changes for Q4 2025 came in at $526000.0, down 55.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (down 18.78% YoY), and the FY2025 annual result was $15396.0, down 64.54% from the prior year.
  • Other Working Capital Changes came in at $526000.0 for Q4 2025 at Beta Bionics, up from $15396.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q4 2024 to a low of $6421.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Beta Bionics 617.66 Mn 587.36 Mn 16.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 526,000.00
Dec 31, 2025 526,000.00
Sep 30, 2025 15,396.00
Sep 30, 2025 15,396.00
Jun 30, 2025 15,396.00
Jun 30, 2025 15,396.00
Mar 31, 2025 6,421.00
Mar 31, 2025 6,421.00
Dec 31, 2024 1.18 Mn
Dec 31, 2024 1.18 Mn
Sep 30, 2024 537,000.00
Sep 30, 2024 537,000.00
Jun 30, 2024 76,000.00
Jun 30, 2024 76,000.00
Mar 31, 2024 1.06 Mn
Mar 31, 2024 1.06 Mn